What disease does dimethyl fumarate (Tecfidera) treat?
Dimethyl fumarate (Tecfidera) is a drug used to treat multiple sclerosis (Multiple Sclerosis, MS ). Multiple sclerosis is a chronic, immune-mediated neurological disease characterized by damage to the myelin sheath of nerves in the central nervous system, resulting in impairment of nerve impulse conduction and, in turn, a series of neurological dysfunctions.
The main ingredient of Tecfidera is dimethyl fumarate, which is a drug that can be administered orally and is an immunomodulator. Its mechanism of action involves the regulation of the immune system. By reducing inflammatory responses and inhibiting the activity of immune cells, it reduces the degree of autoimmune attack on the nerve myelin, thereby delaying the course of multiple sclerosis.

When patients take Tecfidera, they usually need to take it orally twice daily, which is more convenient than other treatment methods that require injection or intravenous infusion, improving patient compliance. The use of Tecfidera can help reduce symptoms, improve quality of life, and slow the progression of the disease to a certain extent in patients with multiple sclerosis.
However, like all drugs, Tecfidera may also be associated with some potential side effects, such as gastrointestinal discomfort, headache, abnormal liver function, etc., so patients should receive a comprehensive medical evaluation before use and use it under the supervision of a doctor. Overall, Tecfideraprovides patients with multiple sclerosis an effective treatment option to help them manage their disease, reduce symptoms, and improve their quality of life.
The original drug of dimethyl fumarate has been launched in China and has been included in medical insurance. Patients can buy it domestically at a price of about 5,000 to 6,000 yuan. Please consult the local hospital pharmacy for specific prices. The main foreign drug is dimethyl fumarate original drug. The cheaper one is the Indian original drug, which costs more than 2,000 yuan and has the same composition and efficacy as the domestic original drug.
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)